February is American Heart Health Month! Shop Heart Medication Specials All Month Long!

Industry News

Auburn continually updates our product portfolio, ensuring that we are offering the most current generics that are available in the market. What’s more, our commitment to consumer and product safety is unparalleled - we notify customers of manufacturer recalls immediately and our protocols align with FDA regulations.


As we do every year, we have just completed a rebid and review of each our products and we’re sure that you’ll be pleased with the results. You’ll find many new items and literally hundreds of price decreases. This is a time when manufacturers also review their pricing and many cases pass on both increases and decreases. You’ll see that in most cases where there was an adjustment it resulted in lower pricing.

If there are any generics that you use and we don’t carry be sure to give you Auburn Account Manager the details and we can probably help you out.

Lower generic pricing is certainly good news for many but not necessarily the manufacturers. Though we continue to hear a lot about increased drug costs the facts show that this isn’t the case with generics over the last few years. Everyone notices when a price goes up significantly but don’t remember just over a year ago when generic Viagra was selling for over $30 per pill, considerably more than the .30 per pill that it currently sells for.

With overall generic prices declining over the last few years, it is no surprise that many generic manufacturers have been struggling or worse. Aceto Corporation filed bankruptcy last year which resulted in their sale of Rising Pharmaceutical.

Pricing problems were one of the big issues faced by Akorn whose stock was trading over $50/share five (5) years ago and is recently trading at less $1.50.

Even Wall Street favorite Teva has been making significant changes to deal with issues, including pricing pressure. Their stock was trading over $60 share and is now in the $10 range.

It looks like this year is going create many changes in the generic industry through acquisitions, mergers, and bankruptcies.

While this may be a difficult time for many manufacturers it has created some opportunities for others. Our list of short-dated and close-out merchandise has never been better. This is a great chance for you to pick up some fantastic specials with GenericBid.com. GenericBid is our weekly auction of these deals and it is very easy to use. You can sign in with your AuburnGenerics.com username and password. It’s a fun and easy way to save a lot! Ask your Auburn Account Manager for the simple details.

image of pills falling out of bottle

Generic Product Launch Dates

Below you will find a list of anticipated new generic launch dates* along with the estimated availability. If you are interested in learning more about which items Auburn Pharmaceutical may carry in the future, please contact us to open your account.

Brand Name Generic Name # of players Estimated Availability*
Zortress Everolims 3 potentially March 2020
Vimovo Esomeprazole/Maproxen 4 potentially 1st Quarter 2020
Sklice Ivermectin 1 Player May 2020
Saphris Asenapine Maleate 3 potentially 1st Half 2020
*This information is intended to provide you with the latest industry news around generic drug launch dates. Please note, there is no guarantee that Auburn Pharmaceutical will supply the listed products. Product release dates are subject to change by evolving market conditions. Launch dates are anticipated, not guaranteed.

Upcoming Events & Promotions

Events coming up that Auburn Pharmaceutical will be attending.

February 19th-22nd, 2020
NCPA Multiple Locations Pharmacy Conference
Marriott Sanibel Harbour Resort & Spa
Fort Myers, Florida

February 21th-22nd, 2020
Michigan Pharmacists Association 2020 Annual Convention & Expo
Detroit Marriott at the Renaissance Center

February 27th-29th, 2020
16th Annual PDS Super Conference
Rosen Shingle Creek Orlando
Orlando, Florida